BlackRock, Inc.

Position in GH — Guardant Health, Inc.

CIK 2012383 New York, NY

Position in GH

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,143,668,930

+$76,448,219 QoQ

Shares Held

7,622,935

-34.0% QoQ

Ownership

5.68%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

of 594 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 94% Shared 0% None 6%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $60,397,006,173 across 41 Diagnostics & Research names. GH ranks #13 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	30,919,632	$15,501,866,689
2	DHR	Danaher Corp /De/	55,084,630	$10,492,520,314
3	IDXX	Idexx Laboratories Inc /De	8,170,178	$4,301,108,497
4	A	Agilent Technologies, Inc.	25,599,001	$3,400,315,293
5	ILMN	Illumina, Inc.	19,191,398	$3,374,423,500
6	WAT	Waters Corp /De/	8,484,939	$3,182,191,513
7	NTRA	Natera, Inc.	10,914,608	$2,962,770,335
8	IQV	Iqvia Holdings Inc.	14,549,693	$2,811,291,673

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,034,495,257	6,895,256	—	Shares	Sole	2026-07-28
2026-06-30	$1,143,668,930	7,622,935	-34.0%	Shares	Sole	2026-08-07
2026-03-31	$1,067,220,711	11,553,759	+2.1%	Shares	Sole	2026-05-13
2025-12-31	$1,155,991,299	11,317,714	-1.0%	Shares	Sole	2026-02-12
2025-09-30	$714,103,594	11,429,315	+4.1%	Shares	Sole	2025-11-12
2025-06-30	$571,371,610	10,979,470	-1.7%	Shares	Sole	2025-08-12
2025-03-31	$476,007,281	11,173,880	-4.5%	Shares	Sole	2025-05-02
2024-12-31	$357,483,476	11,701,587	+2.3%	Shares	Sole	2025-02-07
2024-09-30	$262,331,831	11,435,564	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.